LILRB2/CD85d/ILT4 Domain1 & 2 Protein, Human, Recombinant (His)

Ref. TM-TMPK-01101

Informations sur le produit

• Nom: LILRB2/CD85d/ILT4 Domain1 & 2 Protein, Human, Recombinant (His)
• Synonymes: LILRB2, ILT-4, CD85d, MIR10, LIR2, ILT4, ILT4CD85d

Description

The immunoglobulin-like transcript (ILT) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIR). ILT4, also known as LIR-2 and LILRB2, is a type I transmembrane protein expressed primarily on monocytes and dendritic cells (DC). LILRB2 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. LILRB2/CD85d/ILT4 Domain1 & 2 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 24.2 kDa and the accession number is Q8N423-1.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 24.2 kDa (predicted). Due to glycosylation, the protein migrates to 25-30 kDa based on Tris-Bis PAGE result.
• Couleur/Forme: Solid